Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Steven B. Whittaker

Steven B. Whittaker

Executive Director, Quality Consortium

The Avoca Group, United States

Learning Objective : Discuss different approaches being used by the industry in proactive quality management; Describe how companies measure and implement quality standards; Identify tools for proactive quality management.

Speaker(s)

Jennifer G. Marsh

Panelist

Jennifer G. Marsh

Eli Lilly and Company, United States

Senior Director, Global Medical Quality

Coleen  Glessner, MBA

Panelist

Coleen Glessner, MBA

Alexion Pharmaceuticals, United States

Senior Vice President, Chief Quality Officer

Ann  Meeker-O'Connell, MS

Panelist

Ann Meeker-O'Connell, MS

Novartis, United States

Executive Director, Monitoring Excellence Head

Fergus  Sweeney, PHD

Panelist

Fergus Sweeney, PHD

European Medicines Agency, Netherlands

Head of Clinical Studies and Manufacturing Task Force

Cassandra  Kennedy

Panelist

Cassandra Kennedy

Quintiles Inc., United States

Senior Vice President, Global Quality Assurance

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.